| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 13 | +53.85% | -0.27% | +0.34% | -0.61% | -0.15% | — |
| 14d | 13 | +30.77% | +0.95% | +0.18% | +0.77% | +2.99% | — |
| 30d | 13 | +38.46% | +1.42% | +1.08% | +0.33% | +1.81% | — |
| 60d | 13 | +69.23% | -0.88% | +5.14% | -6.02% | -9.21% | — |
| 90d | 13 | +61.54% | +1.11% | +7.57% | -6.46% | -11.67% | — |
| 180d | 13 | +84.62% | -11.55% | +16.24% | -27.79% | -30.71% | — |
| 1y | 13 | +76.92% | -15.79% | +20.06% | -35.85% | -40.80% | — |
| 2y | 13(1 pending) | +91.67% | -11.97% | +19.94% | -31.91% | -16.40% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| ASRT ASSERTIO HOLDINGS, INC. | SALE CEO | 49,416 | $0.66 | $32.8K | 128,955.462 | May 31, 2025 | Jun 3, 2025 ↗ | View → |
| ASRT ASSERTIO HOLDINGS, INC. | PURCHASE CEO | 166,665 | — | — | 178,371.462 | May 31, 2025 | Jun 3, 2025 ↗ | View → |
| ASRT ASSERTIO HOLDINGS, INC. | SALE CEO | 166,665 | — | — | 333,335 | May 31, 2025 | Jun 3, 2025 ↗ | View → |
| ASRT ASSERTIO HOLDINGS, INC. | PURCHASEGRANT Stock grant | 755,525 | — | — | 755,525 | Feb 18, 2025 | Feb 20, 2025 ↗ | View → |
| ASRT ASSERTIO HOLDINGS, INC. | PURCHASEGRANT Stock grant | 500,000 | — | — | 500,000 | Feb 18, 2025 | Feb 20, 2025 ↗ | View → |
| ASRT ASSERTIO HOLDINGS, INC. | PURCHASE CEO | 11,706.462 | $0.85 | $10.0K | 11,706.462 | Nov 14, 2024 | Nov 15, 2024 ↗ | View → |
| ASRT ASSERTIO HOLDINGS, INC. | PURCHASEGRANT Stock grant | 1,800,000 | — | — | 1,800,000 | May 31, 2024 | Jun 4, 2024 ↗ | View → |
| ASRT ASSERTIO HOLDINGS, INC. | PURCHASEGRANT Stock grant | 500,000 | — | — | 500,000 | May 31, 2024 | Jun 4, 2024 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, North America Commercial | 11,436 | $10.54 | $120.6K | 14,868.486 | Mar 5, 2021 | Mar 8, 2021 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASEGRANT Stock grant | 109,315 | — | — | 109,315 | Mar 5, 2021 | Mar 8, 2021 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, North America Commercial | 18,905 | — | — | 37,811 | Mar 4, 2021 | Mar 8, 2021 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASE EVP, North America Commercial | 18,905 | — | — | 33,773.486 | Mar 4, 2021 | Mar 8, 2021 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, North America Commercial | 7,469 | $10.57 | $78.9K | 26,304.486 | Mar 4, 2021 | Mar 8, 2021 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, North America Commercial | 703 | $10.80 | $7.6K | 14,868.486 | Mar 4, 2021 | Mar 8, 2021 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASE EVP, North America Commercial | 1,166 | — | — | 16,034.486 | Mar 3, 2021 | Mar 4, 2021 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, North America Commercial | 1,166 | — | — | 0 | Mar 3, 2021 | Mar 4, 2021 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, North America Commercial | 463 | $10.86 | $5.0K | 15,571.486 | Mar 3, 2021 | Mar 4, 2021 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, North America Commercial | 15,085 | $10.85 | $163.6K | 14,868.486 | Mar 2, 2021 | Mar 4, 2021 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, North America Commercial | 63,278 | $10.93 | $691.4K | 29,953.486 | Mar 1, 2021 | Mar 2, 2021 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, North America Commercial | 9,849 | $10.83 | $106.7K | 93,231.486 | Mar 1, 2021 | Mar 2, 2021 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, North America Commercial | 24,934 | — | — | 74,805 | Feb 28, 2021 | Mar 2, 2021 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASE EVP, North America Commercial | 24,934 | — | — | 103,080.486 | Feb 28, 2021 | Mar 2, 2021 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASEGRANT Stock grant | 67,852 | — | — | 98,840.486 | Feb 9, 2021 | Feb 11, 2021 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASE EVP, North America Commercial | 16,120 | — | — | 30,988.486 | Feb 9, 2021 | Feb 11, 2021 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, North America Commercial | 16,120 | — | — | 16,121 | Feb 9, 2021 | Feb 11, 2021 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, North America Commercial | 3,974 | $12.69 | $50.4K | 94,866.486 | Feb 9, 2021 | Feb 11, 2021 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, North America Commercial | 16,720 | $12.69 | $212.3K | 78,146.486 | Feb 9, 2021 | Feb 11, 2021 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, North America Commercial | 470 | $7.16 | $3.4K | 14,868.486 | Mar 17, 2020 | Mar 19, 2020 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, North America Commercial | 1,179 | — | — | 0 | Mar 17, 2020 | Mar 19, 2020 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASE EVP, North America Commercial | 1,179 | — | — | 15,338.486 | Mar 17, 2020 | Mar 19, 2020 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, North America Commercial | 463 | $11.37 | $5.3K | 14,159.486 | Mar 3, 2020 | Mar 5, 2020 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, North America Commercial | 1,166 | — | — | 1,166 | Mar 3, 2020 | Mar 5, 2020 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASE EVP, North America Commercial | 1,166 | — | — | 14,622.486 | Mar 3, 2020 | Mar 5, 2020 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASEGRANT Stock grant | 99,739 | — | — | 99,739 | Feb 28, 2020 | Mar 3, 2020 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, North America Commercial | 4,799 | $12.27 | $58.9K | 13,456.486 | Feb 10, 2020 | Feb 11, 2020 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | SALE EVP, North America Commercial | 16,120 | — | — | 32,241 | Feb 9, 2020 | Feb 11, 2020 ↗ | View → |
| TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD | PURCHASE EVP, North America Commercial | 16,120 | — | — | 18,255.486 | Feb 9, 2020 | Feb 11, 2020 ↗ | View → |